StockNews.com upgraded shares of Aspira Women’s Health (NASDAQ:AWH – Free Report) from a sell rating to a hold rating in a report published on Wednesday.
Aspira Women’s Health Stock Down 3.6 %
NASDAQ AWH opened at $1.06 on Wednesday. The firm has a market cap of $17.02 million, a P/E ratio of -0.73 and a beta of 1.54. Aspira Women’s Health has a 52-week low of $0.86 and a 52-week high of $6.75. The business’s 50-day moving average price is $1.39 and its 200 day moving average price is $2.76.
Aspira Women’s Health (NASDAQ:AWH – Get Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported ($0.28) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.32) by $0.04. The company had revenue of $2.42 million for the quarter, compared to analyst estimates of $2.60 million. During the same period in the previous year, the business posted ($0.28) earnings per share. As a group, analysts anticipate that Aspira Women’s Health will post -1.29 earnings per share for the current year.
Institutional Investors Weigh In On Aspira Women’s Health
About Aspira Women’s Health
Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.
Recommended Stories
- Five stocks we like better than Aspira Women’s Health
- What Are Some of the Best Large-Cap Stocks to Buy?
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
- 5 Top Rated Dividend Stocks to Consider
- Warren Buffett’s Recent Stock Moves: Top Buys and Sells to Watch
- Dividend Capture Strategy: What You Need to Know
- Sea Limited’s E-Commerce and Fintech Strength Fuel Stock Surge
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.